About: Impaired immunity to recall antigens and neoantigens in severely immunocompromised children and adolescents during the first year of effective highly active antiretroviral therapy

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Impaired immunity to recall antigens and neoantigens in severely immunocompromised children and adolescents during the first year of effective highly active antiretroviral therapy Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on October 2008

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) article scientifique (fr) artículu científicu espublizáu en 2008 (ast) наукова стаття, опублікована в жовтні 2008 (uk) مقالة علمية نشرت في أكتوبر 2008 (ar) scientific article published on October 2008 (en)
publication date	wds:Q37494145-17643ADC-9765-4FEB-AD49-DA4CFCAC3039
publication date	2008-10-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q37494145-E3D00A54-E448-4D80-8BB2-214C3B6AA654
language of work or name	English
cites work	wds:Q37494145-1B9B1A53-6D6E-4F00-8FCE-C13CF5800088 wds:Q37494145-20417133-D441-4678-9798-06FFE9D69CDE wds:Q37494145-39BBFE3F-C0E5-4435-B246-C7773AA02E8C wds:Q37494145-3AF0C89B-3E18-4407-84F3-FBC0A40CE3FB wds:Q37494145-4DC90E75-05E5-4E63-893A-225EC10396B9 wds:Q37494145-51BC24F8-276C-4CF9-B506-A53EF57952C1 wds:Q37494145-654EF978-9D67-4DD2-9F80-ACC091C7FB25 wds:Q37494145-6CBD737C-10CD-4864-B474-2EE2CE84A48E wds:Q37494145-6DC6868C-9B37-4A88-B927-DE824A161DB8 wds:Q37494145-72DC361C-BA5C-4163-87D5-7E20EF12191E wds:Q37494145-837AFD3F-DE3B-422E-BBCF-4FAB51B7C901 wds:Q37494145-8F298265-8F9E-41D7-929D-D530AD8E3D22 wds:Q37494145-95047E18-2C4A-4E4B-B380-A969EC8E33EE wds:Q37494145-A1420536-FFF9-46C5-AB01-0784BB7BC356 wds:Q37494145-A394BB6B-A84D-498A-99A3-0EA387E13BD9 wds:Q37494145-C509A655-E2B3-4F6B-ADBE-A86BFA660161 wds:Q37494145-CF4F4D66-244E-4932-853B-2EEB62531624 wds:Q37494145-D64FC050-3207-4F28-BFF2-CF6E531F0BD4 wds:Q37494145-E6469EC1-B015-4E4D-A5D8-E7D76EE72B78 wds:Q37494145-E8C6FA9F-936A-4209-B4AC-0B72750CCCFD wds:Q37494145-EE6C8C4E-F1D4-4A4B-B2E0-788A07741ABF wds:Q37494145-FC564978-4DA4-4A7B-9364-E94BF610B888
cites work	ELISA for the routine determination of antitoxic immunity to tetanus Incidence of opportunistic and other infections in HIV-infected children in the HAART era. Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease Changes in thymic function with age and during the treatment of HIV infection Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children Effect of Combination Therapy Including Protease Inhibitors on Mortality among Children and Adolescents Infected with HIV-1 Decrease in hospitalization and mortality rates among children with perinatally acquired HIV type 1 infection receiving highly active antiretroviral therapy. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation. Extensive implementation of highly active antiretroviral therapy shows great effect on survival and surrogate markers in vertically HIV-infected children Immunologic and virologic responses to HAART in severely immunocompromised HIV-1-infected children. Early immune reconstitution after potent antiretroviral therapy in HIV-infected children correlates with the increase in thymus volume Immunoreconstitution in children receiving highly active antiretroviral therapy depends on the CD4 cell percentage at baseline Response to immunization with measles, tetanus, and Haemophilus influenzae type b vaccines in children who have human immunodeficiency virus type 1 infection and are treated with highly active antiretroviral therapy Antibody responses to hepatitis A virus vaccine in HIV-infected children with evidence of immunologic reconstitution while receiving highly active antiretroviral therapy Therapeutic immune reconstitution in HIV-1-infected children is independent of their age and pretreatment immune status. Immune reconstitution in HIV-1-infected children on antiretroviral therapy: role of thymic output and viral fitness Antimicrobial-specific cell-mediated immune reconstitution in children with advanced human immunodeficiency virus infection receiving highly active antiretroviral therapy Tetanus immunity after diphtheria, tetanus toxoids, and acellular pertussis vaccination in children with clinically stable HIV infection Immunogenicity and tolerability of hepatitis A vaccine in HIV-infected children Cell-mediated and humoral immune responses in children infected with human immunodeficiency virus during the first four years of life Correlation of clinical parameters and immunological function with human immunodeficiency virus plasma viremia in children Cellular and humoral immune responses to a tetanus toxoid booster in perinatally HIV-1-infected children and adolescents receiving highly active antiretroviral therapy (HAART)
author name string	wds:Q37494145-065B22E4-51C3-4305-9B1E-AA607EF2A579 wds:Q37494145-424BE0FE-F2DD-4099-BCA3-EDE6D7A41D36 wds:Q37494145-56BBFA75-887A-4D38-94E8-09AB059D4976 wds:Q37494145-8BC442DD-BF58-47AB-8668-6E70BADBCCB1 wds:Q37494145-91610F13-F9A7-48C3-A2CF-0917E7592F8C wds:Q37494145-9D0EA039-87AA-4959-B795-DF2487DA544F wds:Q37494145-9E8F5E28-5A63-47B9-B105-DC88926756ED wds:Q37494145-B3AD5ED4-B8DA-433C-A97E-FFA34045EA0B wds:Q37494145-B48A0581-20DC-499D-A54E-C6BCE57915B3 wds:Q37494145-BA7D02B8-488A-4CE5-96A6-B1BB13E14761 wds:Q37494145-D4425A41-1005-409B-A4BC-4DC496BE8027
author name string	William Borkowsky Jennifer S Read Patrick Jean-Philippe Bonnie Zimmer Joyce Kraimer Terry Fenton Dorothy Smith Mona Rigaud Elaine Fergusson Pediatrics AIDS Clinical Trials Group P1006 Team Phillip Larussa
rdfs:label	Impaired immunity to recall antigens and neoantigens in severely immunocompromised children and adolescents during the first year of effective highly active antiretroviral therapy (en) Impaired immunity to recall antigens and neoantigens in severely immunocompromised children and adolescents during the first year of effective highly active antiretroviral therapy (nl) Impaired immunity to recall antigens and neoantigens in severely immunocompromised children and adolescents during the first year of effective highly active antiretroviral therapy (ast)
skos:prefLabel	Impaired immunity to recall antigens and neoantigens in severely immunocompromised children and adolescents during the first year of effective highly active antiretroviral therapy (en) Impaired immunity to recall antigens and neoantigens in severely immunocompromised children and adolescents during the first year of effective highly active antiretroviral therapy (nl) Impaired immunity to recall antigens and neoantigens in severely immunocompromised children and adolescents during the first year of effective highly active antiretroviral therapy (ast)
name	Impaired immunity to recall antigens and neoantigens in severely immunocompromised children and adolescents during the first year of effective highly active antiretroviral therapy (en) Impaired immunity to recall antigens and neoantigens in severely immunocompromised children and adolescents during the first year of effective highly active antiretroviral therapy (nl) Impaired immunity to recall antigens and neoantigens in severely immunocompromised children and adolescents during the first year of effective highly active antiretroviral therapy (ast)
author	wds:Q37494145-01D07C3B-052D-4C51-852C-14FC6F6F819C wds:Q37494145-F39F7515-3AFB-446F-9671-8225572E8E3C
author	Adriana Weinberg Petronella Muresan

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software